The circulating blood proteome was assayed for the CRC protein markers, such as carbohydrate antigen 19-9 (CA19-9) and carcinoembryonic antigen (CEA); however, both emerged to be insufficiently sensitive and specific, especially for early CRC, and they seem to be insufficient to warrant their widespread use [7]. Here, CEACAM5 is linked to colorectal carcinoma.